Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1

2-Hydroxypropyl-beta-cyclodextrin (HPβCD) has gained recent attention as a potential therapeutic intervention in the treatment of the rare autosomal-recessive, neurodegenerative lysosomal storage disorder Niemann-Pick Disease Type C1 (NPC1). Notably, HPβCD formulations are not comprised of a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Yergey, Alfred L., Blank, Paul S., Cologna, Stephanie M., Backlund, Peter S., Porter, Forbes D., Darling, Allan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393605/
https://www.ncbi.nlm.nih.gov/pubmed/28414792
http://dx.doi.org/10.1371/journal.pone.0175478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393605/
https://www.ncbi.nlm.nih.gov/pubmed/28414792
http://dx.doi.org/10.1371/journal.pone.0175478

Ejemplares similares